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Role of oxidative stress in advanced glycation end product- velopment of kidney disease in animal models of diabe-
induced mesangial cell activation. tes [2, 3] and experimental evidence obtained from in
Background. Levels of advanced glycation end products vitro studies shows that prevention of ROS generation(AGE) are elevated in individuals with advancing age, renal
defends against the damaging effects of a hyperglycemicfailure, and diabetes, and accumulation of these molecules may
milieu on mesangial cell function [4, 5]. In both models,contribute to disease progression. The mechanism by which
AGE proteins alter glomerular mesangial cell function, how- the therapeutic effect of antioxidants appears directly
ever, is not completely understood. The present study assessed related to their ability to normalize key early intracellu-
the involvement of oxidative stress in AGE-dependent mesan- lar signaling events linked to the development and pro-
gial cell signaling events. gression of diabetic nephropathy.Methods. Primary cultures of rat renal mesangial cells were
Advanced glycation end products (AGEs) also play aexposed to in vitro AGE-BSA and H2O2. Nuclear factor-B
significant role in the pathogenesis of vascular and renal(NF-B) and protein kinase C (PKC) isoform activation were
studied using confocal microscopy and Western blotting. Quan- complications associated with diabetes [6–8]. These toxic
titative polymerase chain reaction (PCR) was used to measure molecules represent a heterogeneous group whose level
transforming growth factor-1 (TGF-1) levels. The involve- in plasma and tissue is determined by glycemic control,ment of oxidative stress was assessed by supplementing or
turnover rate of proteins, and renal function [9, 10]. AGEscompromising cellular antioxidant capacity.
accumulate in glomerular regions of the kidney [8, 11,Results. NF-B was dose-dependently activated by AGE.
PKC activation was not involved in this response, but analysis 12] and infusion of AGE-modified proteins into experi-
of PKC-1 activation showed a stimulatory effect of AGE mental animals leads to renal complications similar to
proteins on this isoform. Transcription of TGF-1 was stimu- those observed in diabetic nephropathy [13, 14]. Directlated by AGE and was prevented by PKC inhibition. Challenge
cellular challenge with AGE has been shown to causewith H2O2 had similar downstream effects on mesangial cell
oxidative stress in various cell types [15–17] includingsignaling. Antioxidants, vitamin E and nitecapone, prevented
AGE-dependent NF-B activation and normalized PKC activ- mesangial cells [18], but the specific involvement of ROS
ity and associated TGF-1 transcription. Depletion of the intra- in AGE-dependent mesangial cell signaling has not been
cellular antioxidant, glutathione, effectively lowered the AGE examined previously.
concentration needed for mesangial cell activation of NF-B
The current study was therefore designed to identifyand PKC-1. Treatment with a suboptimal AGE dose, under
the extent to which ROS are involved in AGE-inducedglutathione-depleted conditions, revealed a synergistic effect
on both parameters. alterations in mesangial cell function. To probe this re-
Conclusion. The results support a central role for oxidative lationship, we examined the regulation of nuclear fac-
stress in AGE-dependent mesangial cell signaling and empha- tor-B (NF-B), protein kinase C (PKC), and trans-
size the importance of ROS in determining cell responsiveness.
forming growth factor-1 (TGF-1), since these factors
occupy key positions in the cellular events associated
with diabetes. We demonstrate here that AGE causeSeveral lines of evidence demonstrate that oxidative
increased mesangial cell oxidative stress and that thisstress or reactive oxygen species (ROS) are involved in early event is implicated in the independent activation
the pathogenesis of diabetes [1]. We and others have of NF-B and the PKC pathway. Additionally, we show
shown that antioxidant therapy protects against the de- that ROS play a key role in determining the magnitude
of AGE-induced activation of PKC-1 and NF-B.
Key words: AGE, diabetes, oxidative stress, NF-B, protein kinase C,
TGF-1.
METHODS
Received for publication August 23, 2001
Materialsand in revised form January 23, 2002
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poo, Finland). Rabbit polyclonal PKC isoform-specific to treatment with AGE or other agents according to the
various treatment conditions. Following stimulation, cellsand NF-B p65 antibodies were purchased from Santa
Cruz (Santa Cruz, CA, USA). Texas–red-conjugated anti- were fixed with 3.5% formaldehyde/PBS for 10 minutes,
permeabilized with 0.1% Triton X-100 for 15 minutes,rabbit secondary antibody was from Molecular Probes
(Leiden, The Netherlands). Moloney-murine leukemia and blocked with 1% goat serum, 0.1% BSA for one
hour. Cells were then stained with NF-B (1:200) orvirus (M-MLV)-reverse transcriptase, RNasin, and Oligo
dT were obtained from Promega (Madison, WI, USA). PKC-1 (1:200) antibodies for one hour at room temper-
ature or overnight at 4C, followed by washing and subse-Taq polymerase and dNTPs were from Perkin Elmer
(Foster City, CA, USA). All other chemicals were pur- quent recognition with Texas-red-conjugated secondary
antibody (1:200). The cells were washed again andchased from Sigma Chemical Co. (St. Louis, MO, USA).
mounted in Prolong antifade. Fluorescence images were
Isolation and primary culture of mesangial cells recorded using a Zeiss LSM410 inverted confocal scan-
ning laser microscope with excitation at 543 nm and long-Kidney cortex, isolated from male Sprague-Dawley
rats, was chopped on ice and passed through a series of pass detection at 570 nm (Carl Zeiss Instruments, Zurich,
Switzerland). Optical sections through the center of thenylon meshes of graded pore sizes (150, 105, and 77
mol/L) by applying gentle pressure and repeated wash- cells were used for localization of the immunofluorescent
signal. For the NF-B studies, cell staining was semi-ing with phosphate-buffered saline (PBS; pH 7.4) supple-
mented with antibiotics (100 U/mL of penicillin and 100 quantitatively estimated by measuring the redistribution
of immunofluorescent signal between the nucleus andg/mL of streptomycin). Glomeruli collected from the
final 77mol/L collection sieve were rinsed and collagen- cytoplasm. Two persons blind to the protocol performed
the calculations using Scion Image software. Nucleusase (100 mg/100 mL) digested for 15 minutes prior to
plating in Dulbecco’s modified Eagle’s medium (DMEM; localization was confirmed with Sytox Green nuclear
stain (Molecular Probes). Cells revealed no auto-fluo-Life Technologies) containing 20% fetal bovine serum
(FBS; Life Technologies), antibiotics, 24 mmol/L NaHCO3, rescence and control sections incubated without primary
antibody and with secondary antibody displayed no sig-and 20 mmol/L HEPES. Mesangial cells obtained from
glomerular outgrowths were used from passages 3 to 10. nificant background signal. Negative controls for PKC-1
immunofluorescence performed with primary antibodiesMesangial cells had a predominantly fusiform or stellate
appearance on phase-contrast microscopy. Positive im- preabsorbed to its immunizing peptide showed very weak
staining. Three to five individual experiments were per-munofluorescent staining for smooth muscle -actin and
negative staining for von Willebrand factor and cytoker- formed and 9 to 25 cells were analyzed for each experi-
mental condition.atin confirmed the purity of mesangial cell cultures and
absence of contaminating endothelial and epithelial cell
Determination of thiobarbiturictypes. Under all experimental treatment conditions, mes-
acid-reactive substancesangial cells were serum-starved over night in DMEM
containing 0.5% FBS prior to treatment. Analysis of mesangial cell lipid peroxide content was
determined by measuring the abundance of thiobarbi-
AGE-BSA preparation turic acid-reactive substances (TBARS) [19]. Briefly,
mesangial cells, treated for 72 hours with 100 g/mLGlycated bovine serum albumin (BSA) with AGE for-
mation was prepared in vitro by incubating 50 mg/mL AGE in the presence or absence of antioxidants, were
scraped off 60 mm plates and sonicated in 1.15% KClBSA with 0.15 mol/L ribose in sterile phosphate buffer
(pH 7.4) containing antibiotics at 37C for 14 days. Con- solution followed by solubilization with an equal volume
of 8% sodium dodecyl sulfide (SDS). To this mixture,trol non-glycated BSA (50 mg/mL) was prepared in the
same manner without ribose supplementation. AGE- 20% acetic acid and 0.8% thiobarbituric acid were added.
The complete mixture was heated to 95C for 60 minutes,BSA and control BSA were dialyzed against PBS over-
night to remove ribose, sterile-filtered through 0.2 m after which the chromogenic substrate was extracted into
the organic phase with butanol/pyridine (15:1). Absor-filters (Sartorius), aliquoted and stored at 80C until
needed. Estimation of AGE content by spectrofluorom- bance of the organic layer was measured with a spectro-
fluorometer with excitation wavelength of 515 nm andetry with excitation wavelength of 390 nm and emission
wavelength of 450 nm revealed a 10.7-fold increase in emission wavelength of 553 nm. Absorbance was mea-
sured relative to a standard using 1,1,3,3-tetramethoxy-fluorescence for AGE-BSA compared to control BSA
at a concentration of 200 g/mL. propane.
Cell fractionationImmunostaining and confocal microscopy
Mesangial cells grown to subconfluence on glass cover- For the PKC experiments, confluent, serum-starved,
mesangial cells grown on 100 mm plates were treatedslips were serum-starved for 24 hours in 0.5% FBS prior
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with 200 g/mL AGE for 60 minutes in the presence or protein loading between lanes within individual blots
was confirmed with amido black dye staining.absence of antioxidants. Following treatment, cells were
rinsed with ice-cold PBS and resuspended in buffer A
Semiquantitative PCR of TGF-1containing 50 mmol/L Tris-HCl (pH 7.4), 120 mmol/L
Confluent cultures of mesangial cells were treated forNaCl, and Complete protease inhibitor cocktail (Roche,
72 hours with 100 g/mL AGE in the presence or ab-Mannheim, Germany) followed by brief sonication (3 
sence of antioxidants. Total RNA was extracted using a5 seconds at setting 2 using a Branson Sonifier). The cell
commercially available kit (RNeasy KIT; Kiagen, Hil-sonicate was centrifuged at 100,000  g for 60 minutes
den, Germany) and 1 g was reverse transcribed in aat 4C. The supernatant was kept as the cytosolic fraction
standard reaction mixture [2]. PCR analysis was carriedand the resultant pellet was resuspended in buffer A
out for 29 cycles according to the following sequence:supplemented with 1% (vol/vol) Triton X-100, sonicated
denaturation (95C for 30 seconds), primer annealingand incubated on ice for 30 minutes. Centrifugation at
(57C for 45 seconds), and extension (72C for 60 sec-100,000 g for 60 minutes at 4C produced a supernatant
onds). TGF-1 primers: 5-AAG CAC CCG GGT TGT(membrane) fraction containing detergent-soluble pro-
GTT GGT T-3, 5-GTC AGA CAT TCG GGA AGCteins. Protein concentration was determined using the
AGT G-3. -actin primers: 5-TCC TGA CCC TGABio-Rad detergent-compatible protein assay with BSA
AGT ACC CCA TTG-3, 5-GTC GCC TTC ACC GTTas a standard.
CCA GTT-3. PCR products were separated by poly-For assessing NF-B nuclear translocation after treat-
acrylamide gel electrophoresis (PAGE) and were quanti-ment, mesangial cells were rinsed with PBS and resus-
fied using a phosphor imager system and Biorad Quantitypended in ice-cold hypotonic buffer containing 10 mmol/L
One software.HEPES, pH 7.9, 10 mmol/L KCl, 1.5 mmol/L MgCl2, and
Complete protease inhibitor cocktail. After 15 minutes, Statistical analysis
NP-40 was added to 0.1% (vol/vol) and lysates were
Data are expressed as means 	 SE. Differences be-centrifuged at 500 g for 5 minutes. The resulting super-
tween means were evaluated by analysis of variancenatant was collected and used as the cytosolic fraction.
(ANOVA) and the Student t test. Statistical significanceCrude nuclear pellets were rinsed twice with hypotonic
was accepted at P 
 0.05.buffer and resuspended in hypertonic buffer containing
20 mmol/L HEPES, pH 7.9, 420 mmol/L NaCl, 1.5 mmol/L
MgCl2, 25% glycerol and Complete protease inhibitor RESULTS
cocktail. The suspension was rotated for 30 minutes at The current series of experiments tested whether
4C and then centrifuged at 10,000  g for 30 minutes AGE-BSA was an adequate stimulus for activation of
at 4C to yield a supernatant containing extracted nuclear the nuclear transcription factor, NF-B, since regulation
proteins. Protein concentration was determined as de- of this protein has previously been shown to be sensitive
scribed above. to oxidant stress [20]. In its inactive state, NF-B is main-
tained as a latent form present in the cytoplasm where
Immunoblotting of PKC-1 and NF-B
it is bound to a protein complex that masks the nuclear
Equal amounts of protein (cytosolic and membrane localization signal. Exposure of serum-starved mesangial
or nuclear) were loaded onto 8% SDS-PAGE gels, elec- cells to 200 g/mL AGE, under normal glycemic condi-
trophoresed, and transferred to polyvinylidine difluoride tions (5.5 mmol/L glucose) for 30 minutes resulted in
(PVDF) membranes (Amersham Pharmacia Biotech). NF-B activation, as depicted by its enhanced transloca-
Membranes were blocked in 5% milk/PBS for one hour tion to the nucleus (Fig. 1A). Neither non-glycated BSA
at room temperature or overnight at 4C. Membranes nor AGE-BSA prepared in the presence of the nonenzy-
were subsequently rinsed with 0.1% Tween 20 PBS matic glycation inhibitor, 200 mmol/L aminoguanidine
(TPBS) and incubated with PKC-1 (1:2000) or NF-B hemisulfate (AG), had a significant effect on NF-B
(1:5000) antibody for one hour. Following primary anti- nuclear translocation (Fig. 1 A, B). Semiquantification
body incubation, membranes were rinsed and exposed of AGE-mediated NF-B activation revealed a time- and
to goat anti-rabbit secondary antibody (1:5000) for one dose-dependent pattern of nuclear translocation (Fig. 1C).
hour. Immunosignals were visualized using Amersham NF-B nuclear translocation remained elevated by two-
Pharmacia Biotech’s ECL Plus reagents according to the fold after an extended AGE exposure of 48 to 72 hours.
manufacturer’s specifications. Single bands for PKC-1 Western blotting of total cell protein with anti-NF-B
and NF-B were quantified using BioRad Quantity One antibody revealed a consistent level of NF-B expression
software. Specificity of the PKC-1 signal was confirmed following short- and long-term AGE treatment. Cell frac-
by the disappearance of the putative signal by preincuba- tionation of cytosolic and nuclear proteins followed by
Western blotting confirmed NF-B translocation to thetion of the antibody with its competing peptide. Accurate
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Fig. 1. Effect of advanced glycation end products (AGE)-bovine serum albumin (BSA) on mesangial cell nuclear factor-B (NF-B) immunolocali-
zation. (A) Representative confocal micrographs of NF-B staining in mesangial cells treated with 200 g/mL non-glycated BSA, 200 g/mL AGE,
and aminoguanidine (AG)-BSA for 30 minutes. Enhanced nuclear luminosity can be clearly identified in AGE treated cells. (B, C ) Cumulative
semiquantitative data depicting the increase in NF-B nuclear staining obtained from confocal images of cells treated under the various conditions.
Summarized data are means 	 SEM of 4 to 5 different experiments and are representative of data collected from 45 to 125 cells. Symbols in C
are: () 120 minutes; () 60 minutes; () 30 minutes; () 15 minutes; (X| ) BSA. * P 
 0.005 compared to AGE-treated cells.
nucleus and corroborates results observed with immu-
nocytochemistry and confocal microscopy (result not
shown).
Similar to results from others [21], we found that H2O2
rapidly activates NF-B in mesangial cells. To test the
efficacy of antioxidants in abrogating this response, mes-
angial cells were exposed to 0.1 mmol/L nitecapone and
50 g/mL vitamin E (-tocopherol acetate) during 100
mol/L H2O2 treatment. Vitamin E acts a free radical
chain-breaking antioxidant [22]. Nitecapone is a potent
antioxidant that readily scavenges ROS [23] and we have
previously shown that this agent reverses renal abnor-
malities in diabetic rats [2]. Both antioxidants proved
effective in preventing H2O2-induced NF-B transloca- Fig. 2. Effect of antioxidants on AGE- and H2O2-induced mesangial
cell NF-B activation. Symbols are: () control; () H2O2; ( ) AGE.tion (Fig. 2). To assess whether oxidative stress was im-
Cells were pretreated with antioxidants, 0.1 mmol/L nitecapone or 50plicated in the observed AGE-dependent NF-B acti-
g/mL vitamin E, for 30 minutes and then exposed to 200 g/mL AGE
vation, cells were treated with antioxidants 30 minutes (30 min) or 5 to 50 mol/L H2O2 (10 min). The effect of the various
treatments on NF-B nuclear localization was analyzed by immuno-prior to and during AGE exposure. Compared with
staining and was semiquantitatively estimated. Summarized data areAGE-treated cells, little NF-B nuclear translocation mean 	 SE of four different experiments and are representative of
data collected from 30 to 60 cells.was noted when antioxidants were present with 200
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g/mL AGE (Fig. 2; fold increase in NF-B nuclear
translocation compared to control: 200 g/mL AGE
2.25 	 0.089, 200 g/mL AGE  0.1 mmol/L nitecapone
1.38 	 0.095, 200 g/mL AGE  vitamin E 1.205 	
0.063). These results support the conclusion that AGE
cause oxidative stress and that activation of NF-B may
be used as a marker for oxidative stress in this cell system.
Protein kinase C is an enzyme often implicated in the
activation of NF-B. Direct stimulation of mesangial cell
PKC with 0.1 mol/L phorbol ester, PDBu, caused a
rapid (within 10 min) and robust translocation of NF-B
(result not shown). To determine whether PKC was in-
volved in AGE-dependent NF-B nuclear translocation
in the present study, we used the PKC inhibitor, Ro31-
8220, a specific but not the isoform-selective PKC inhibi-
tor. This maneuver did not cause a significant reduction
in NF-B activation (fold increase in NF-B nuclear
translocation compared to control: 200 g/mL AGE
2.36 	 0.38, 200 g/mL AGE  1 mol/L Ro31-8220
2.12	 0.40, NS; 40 to 50 cells from 3 experiments). Ro31-
8220 also was ineffective in preventing NF-B activation
following long-term AGE exposure. To determine sepa-
rately whether PKC was activated downstream of AGE-
BSA, by a pathway independent of NF-B, PKC iso-
form-specific immunocytochemistry and Western blot
analysis were performed for PKC- and PKC-1, two
isoforms commonly implicated in diabetes-induced cellu-
lar dysfunction [2, 24]. Under control conditions (200
g/mL non-glycated BSA), PKC-1 staining was dis-
tributed uniformly throughout the cytoplasm with a vari-
Fig. 3. Effect of AGE-BSA on mesangial cell PKC-1 immunolocali-able degree of nuclear staining. In contrast, treatment
zation. (A) Representative confocal micrographs of PKC-1 stainingwith 200g/mL AGE for 60 minutes caused a prominent in mesangial cells treated with 200 g/mL non-glycated control BSA
perinuclear and membrane-associated increase in PKC-1 or 200 g/mL AGE-BSA for 60 minutes in the presence or absence
of 0.1 mmol/L nitecapone (nit) or 50 g/mL vitamin E (vit E). (B)localization (Fig. 3A). The kinase response was not
Representative immunoblot (upper panel) of PKC-1 expression inreadily observed after 30 minutes, but was maintained cytosol (c) and detergent-soluble particulate (p) fractions obtained from
for longer treatment periods up to at least 48 hours mesangial cells treated as described in A. Eight micrograms of protein
were loaded in each lane The position of molecular weight markers(result not shown). Treatment of mesangial cells with
(kD) is indicated to the left of the blot. Data obtained by densitometricAGE did not have an observable effect on PKC- iso- analysis of five blots are presented in the lower panel as mean 	 SE.
form distribution, a result similar to that observed pre- Symbols are: () cytosol; () particulate; * P 
 0.05 compared to
particulate of AGE-treated cells.viously [25]. The involvement of additional PKC iso-
forms was not studied. Co-incubation with vitamin E and
nitecapone normalized AGE-induced PKC-1 staining.
Western blot analysis of cytosolic and detergent soluble brane component by 45% compared to untreated cells
proteins following 200 g/mL AGE-BSA treatment for (N  4, P 
 0.05).
60 minutes gave results consistent with those obtained Since TGF-1 is causally involved in diabetic glomer-
by immunostaining (Fig. 3B). Membrane-associated ular disease and the PKC pathway is thought to regulate
PKC-1 expression after AGE treatment was increased its expression, we next looked at whether increases in
by 56% compared to control BSA. Expression was re- AGE-dependent ROS generation were implicated in
duced toward control values to a similar extent by both TGF-1 regulation in our cell system. By quantitative
antioxidants. No significant change in cytosolic expres- PCR, we observed a 29% increase in TGF-1 mRNA
sion was noted. Total cellular PKC-1 protein expression relative to -actin when cells were incubated for 72 hours
was unaltered under all treatment conditions. Sensitivity with 100 g/mL AGE (Fig. 4). Mesangial cells co-incu-
of the PKC isoform translocation to oxidative stress was bated with antioxidants during AGE-BSA exposure dis-
confirmed by exposure to H2O2. Treatment of mesangial played control levels of TGF-1 transcript. The involve-
ment of PKC in the TGF-1 response to AGE wascells with 100 mol/L H2O2 increased the PKC-1 mem-
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Fig. 4. Effect of antioxidants on AGE-induced TGF-1 transcript ex-
pression. Mesangial cells were exposed to 100 g/mL AGE for 72 hours
in the presence or absence of 0.01 mmol/L nitecapone (nit), 50 g/mL
vitamin E (vit E) and 1 mol/L Ro31-8220 (Ro). Semiquantitative PCR
was used to measure TGF-1 mRNA expression. -actin was used to
standardize quantification. Values are given as the mean 	 SE of four
independent experiments. * P 
 0.05 vs. other groups.
further supported by the inhibitory effect of PKC inhibi-
tor, Ro31-8220. Analysis of TBAR content, a measure
of oxidative stress, following 72 hours of 100 g/mL
AGE exposure confirmed a chronic elevation in oxida-
tive stress (control 1.12 	 0.140 nmol/mg; 100 g/mL
AGE 1.48	 0.155 nmol/mg; N 7, P
 0.05). Vitamin E
effectively prevented this response (100 g/mL AGE 
50 g/mL vitamin E 0.983 	 0.101 nmol/mg).
Based on the observed central role of ROS in AGE-
dependent signaling, we set out to test whether cellular
antioxidant capacity was involved in determining the
magnitude of response to AGE-BSA. To reduce anti-
oxidant capacity, experiments were performed on cells
Fig. 5. Effect of glutathione depletion on NF-B and PKC-1 activa-that had been depleted of intracellular glutathione. This tion by sub threshold AGE-BSA. Mesangial cells were treated with
was achieved by exposing cells to diethyl maleate (DEM). 1 mmol/L DEM for 90 minutes followed by continued incubation with 20
g/mL nonglycated BSA () or 20 g/mL AGE () for 30 minutes. (A;In preliminary experiments we determined the appro-
upper panel). Cumulative semiquantitative data of NF-B nuclear stainingpriate dose of DEM that was non-toxic to cells and that obtained from confocal images of cells treated under the various conditions.
did not induce a significant response in NF-B nuclear Cells were incubated with 50 g/mL vitamin E (vitE) during DEM/
AGE treatment. Summarized data are means 	 SEM of four differenttranslocation. When cells were pretreated with 1 mmol/L
experiments and are representative of data collected from 40 to 60 cells.DEM for 90 minutes followed by additional 30 minutes *P 
 0.005 other groups. (Lower panel) Representative Western blot
of incubation with 20 g/mL non-glycated BSA, there depicting cytosol and nuclear NF-B expression following treatment as
described above. Five micrograms of protein were loaded in each lane.was no observed effect on NF-B nuclear localization.
(B) Representative Western blot of cytosol (2 g protein) and detergent-However, when a non-stimulatory dose of 20g/mL AGE- soluble (8 g protein) particulate PKC-1 protein content. The position
BSA was substituted for non-glycated BSA, NF-B nu- of molecular weight markers (kD) is indicated to the left of each blot.
clear translocation, assessed by immunocytochemistry and
cell fractionation/Western blotting, was synergistically in-
duced. These results are depicted in Figure 5 A and B. showed a synergistic activation of PKC-1 upon AGE/
To confirm that this effect was dependent on a change DEM co-incubation (Fig. 5C). Cytosolic PKC-1 expres-
in antioxidant capacity and increased oxidative stress, sion decreased and membrane-associated PKC-1 con-
cells were incubated with vitamin E during AGE/DEM tent increased. Vitamin E also was effective in preventing
treatment. The synergistic effect of AGE/DEM on NF-B PKC-1 translocation (not shown).
was significantly blunted by antioxidant supplementation
(Fig. 5A). Next, we examined whether glutathione de-
DISCUSSIONpletion had a similar effect on AGE-dependent PKC-1
activation. Western blotting of cytosolic and detergent Altered levels of circulating antioxidants [26, 27], in-
tracellular scavenging enzymes [28], and increased amountssoluble PKC-1 following treatment as described above
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of oxidatively modified cellular components [26, 29, 30] gions within the cell is important because translocation
of PKC is indicative of kinase activation and modificationprovide evidence for increased oxidative stress in diabe-
tes. The current study shows, to our knowledge for the of PKC signaling processes. The significance of PKC-
activation, and lack of PKC- activation, by AGE-BSAfirst time in mesangial cells, that oxidative stress is a cen-
tral mediator of AGE-dependent activation of NF-B indicates a certain degree of isoform selectivity [18, 25].
While the nature of the AGE-dependent activation ofand PKC/TGF-1 pathways, and highlights the poten-
tial importance of this signaling system in diabetic ne- PKC-1 remains undefined, preliminary data obtained
using sodium borohydride-reduced AGE suggests thatphropathy.
The transcription factor NF-B is a pleiotropic regula- the observed response is specific to AGE compounds,
and not to Amadori products present in our AGE prepa-tor of the inducible expression of many genes and it is
activated by a wide variety of stimuli associated with ration [34]. The mechanism and importance of isoform-
specific PKC activation in the face of AGE challengestress or injury [20]. It is a dimer of two proteins, (one
of which is p65), that reside in the cytoplasm of unstimu- and the significance of similar in vitro findings to diabetic
nephropathy are currently under examination.lated cells, and can be rapidly induced to enter the nu-
cleus by appropriate signaling events, including ROS Exposure of mesangial cells to AGE proteins has been
previously shown to activate PKC-2 [18] and to increasechallenge, as observed here. A study by Scivittaro et
al demonstrates that AGE cause ROS generation and TGF-1 expression [35]. The results presented here sug-
gest a central role for ROS in precipitating both AGE-oxidative stress in mesangial cells, but the role of these
modified proteins in NF-B activation was not described induced PKC activation and TGF-1 transcription. As
supported by our results obtained after AGE or H2O2[18]. Based on the current observations, the largely simi-
lar inhibitory effects of nitecapone and vitamin E on both treatment, mesangial cell PKC-1 activation is sensitive
to, and at least partially determined by, cellular oxidativeH2O2 and AGE-induced NF-B translocation suggests a
common mechanism of activation involving ROS. AGE- stress levels [36]. In diabetic animals and mesangial cells
exposed to hyperglycemic media, antioxidants are thoughtinduced NF-B activation has been described in other
cell types [15, 17, 31], but to our knowledge this is the to prevent TGF-1 induction through their inhibitory ac-
tion on upstream PKC [2–5]. The ability of both anti-first study to address the response in mesangial cells.
The oxidative stress-sensitive steps involved in NF-B oxidants and PKC inhibitors to reduce AGE-induced
TGF-1 levels, as seen here, indicates a similar mode ofactivation remain unexamined, but our preliminary find-
ings indicate that IB, the inhibitory subunit that main- action. Accordingly, it appears that AGE proteins induce
an oxidative stress that impinges on a pathway leading totains NF-B in an inactive state, is degraded upon short-
term AGE treatment. This suggests that ROS likely act PKC activation and associated TGF-1 expression. We
speculate the following about the central role of cellularat a site located upstream of NF-B. Another important
issue regarding the signaling cascade evoked by AGE antioxidant homeostasis in determining mesangial cell re-
sponse sensitivity.treatment is the mechanism by which it causes oxidative
stress. AGE may interact with any one of a number of Cells actively maintain a proper level of intracellular
ROS through defense systems including antioxidant en-heterogeneous AGE-binding proteins expressed in the
plasma membrane of various cell types [7]. Previous stud- zymes and low molecular weight antioxidants. In diabe-
tes the antioxidant capacity is compromised [2, 26, 28,ies indicate that AGE proteins prepared in vitro possess
similar cross-reactive AGE epitopes that are common 29], and this may be important in determining the extent
of AGE-mediated cell signaling events. Glutathione isto proteins modified by AGE in vivo [31], and that inter-
action of these molecules with the cell-associated recep- the major intracellular antioxidant and incubation of cells
with DEM lowers glutathione levels and correspondinglytor for AGE (RAGE) is associated with ROS generation
and NF-B activation [16, 17]. The mechanism of NF-B exposes cells to an increased sensitivity to oxidative stress
[37, 38]. Here, we found that DEM sensitized mesangialspecific activation under conditions of oxidative stress
remains elusive, but a recent study suggests that NADPH cell AGE-responsiveness and lead to enhanced NF-B
and PKC-1 activation. Based on these results, we pro-oxidase plays an important role in AGE-RAGE depen-
dent ROS generation and gene activation [32]. Mesan- pose that depletion of cellular glutathione reduces the
antioxidant capacity of the cell and increases sensitivitygial cells express RAGE and additional experiments are
needed to confirm whether this receptor is a relevant to oxidative stress-dependent AGE signaling. We think
it likely that depletion of GSH antioxidant capacity bymediator of the responses observed here.
Protein kinase C activation is a well-recognized, early DEM is the major contributing factor since we found
that inhibition of the glutathione-synthesizing enzyme,step associated with the initiation and progression of
cellular dysfunction accompanying diabetic microvas- -glutamylcysteine synthetase, with 0.1 mmol/L buthio-
nine sulfoximine, a strategy that also depletes cells ofcular disease [24, 33]. The observed redistribution of cell-
ular PKC-1 to perinuclear and detergent-soluble re- glutathione, also increased cellular sensitivity to sub-
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tion in diabetic rats by treatment with d--tocopherol. J Am Socthreshold doses of AGE-BSA. The ability of antioxi-
Nephrol 8:426–435, 1997
dant supplementation to defend against diminished re- 4. Studer RK, Craven PA, DeRubertis FR: Antioxidant inhibition
dox capacity and increased AGE sensitivity suggests that of protein kinase C-signaled increases in transforming growth fac-
tor- in mesangial cells. Metabolism 46:918–925, 1997ROS are involved in determining the degree of mesan-
5. Tada H, Ishii H, Isogai S: Protective effect of D--tocopherol on
gial cell activation. the function of human mesangial cells exposed to high glucose
concentrations. Metabolism 46:779–784, 1997In terms of diabetic nephropathy, it is important to
6. Brownlee M, Cerami A, Vlassara H: Advanced glycosylationconsider that variations in ROS sensitivity may partially
end products in tissue and the biochemical basis of diabetic compli-
determine individual susceptibility to disease complica- cations. N Engl J Med 318:1315–1321, 1988
7. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP: AGEstions. With respect to diabetic glomerular tissue damage,
and their interaction with AGE-receptors in vascular disease andevidence supports the parallel occurrence of diminished
diabetes mellitus. I. The AGE concept. Cardiovasc Res 37:586–
antioxidant capacity and increased local oxidative stress 600, 1998
8. Makita Z, Radoff S, Rayfield EJ, et al: Advanced glycosylationin this nephron segment of diabetic patients [11]. One
end products in patients with diabetic nephropathy. N Engl J Medcan therefore consider that the magnitude of AGE-
325:836–842, 1991
dependent signaling events occurring through oxidative 9. Vlassara H: Recent progress in advanced glycation end products
and diabetic complications. Diabetes 46(Suppl 2):S19–S25, 1997stress-sensitive steps is amplified and thereby corresponds
10. Brownlee M: Advanced protein glycosylation in diabetes andto more severe cell activation in this region. Based on
aging. Annu Rev Med 46:223–234, 1995
our results and those of others, it is possible that ROS 11. Suzuki D, Miyata T, Saotome N, et al: Immunohistochemical
evidence for an increased oxidative stress and carbonyl modifica-represent a signaling mechanism common to both hyper-
tion of proteins in diabetic glomerular lesions. J Am Soc Nephrolglycemia- and glycated protein-mediated cellular activa-
10:822–832, 1999
tion. Such a possibility for overlapping intracellular sig- 12. Ono Y, Aoki S, Ohnishi K, et al: Increased serum levels of ad-
vanced glycation end-products and diabetic complications. Diabe-naling mechanisms highlights the potential for targeting
tes Res Clin Pract 41:131–137, 1998early cellular activation in diabetes.
13. Yang CW, Vlassara H, Peten EP, et al: Advanced glycation end
The present study supports the concept that in diabe- products up-regulate gene expression found in diabetic glomerular
disease. Proc Natl Acad Sci USA 91:9436–9440, 1994tes, ROS and AGE converge in establishing cell dysfunc-
14. Vlassara H, Striker LJ, Teichberg S, et al: Advanced glycationtion and organ damage. Hyperglycemia accelerates the
end products induce glomerular sclerosis and albuminuria in nor-
synthesis and tissue deposition of AGE, and a positive mal rats. Proc Natl Acad Sci USA 91:11704–11708, 1994
15. Bierhaus A, Chevion S, Chevion M, et al: Advanced glycationcorrelation between serum AGE and the progression of
end product-induced activation of NF-B is suppressed by -lipoicdiabetic nephropathy underscores the probable toxicity
acid in cultured endothelial cells. Diabetes 46:1481–1490, 1997
of these molecules. Our results point to a ROS-depen- 16. Lander HM, Tauras JM, Ogiste JS, et al: Activation of the recep-
tor for advanced glycation end products triggers a p21(ras)-depen-dent signaling effect of AGE proteins in mesangial cells
dent mitogen-activated protein kinase pathway regulated by oxi-and a causative role for these molecules in initiating cell-
dant stress. J Biol Chem 272:17810–17814, 1997
ular events associated with diabetic complications. The 17. Yan SD, Schmidt AM, Anderson GM, et al: Enhanced cellular
parallel occurrence of AGE-mediated oxidative stress oxidant stress by the interaction of advanced glycation end prod-
ucts with their receptors/binding proteins. J Biol Chem 269:9889–and diminished antioxidant defense observed in diabe-
9897, 1994tes may accelerate disease progression and supports the 18. Scivittaro V, Ganz MB, Weiss MF: AGEs induce oxidative stress
potential value of antioxidants in providing disease and activate protein kinase C-(II) in neonatal mesangial cells.
Am J Physiol (Renal Physiol) 278:F676–F683, 2000protection.
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